-
1
-
-
0036490442
-
Smart drugs: Tyrosine kinase inhibitors in cancer therapy
-
Shawver, L. K., Slamon, D., and Ullrich, A. (2002) Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1, 117-123.
-
(2002)
Cancer Cell
, vol.1
, pp. 117-123
-
-
Shawver, L.K.1
Slamon, D.2
Ullrich, A.3
-
2
-
-
0028000069
-
Signal-transduction therapy
-
Levitzki, A. (1994) Signal-transduction therapy. Eur. J. Biochem. 226, 1-13.
-
(1994)
Eur. J. Biochem
, vol.226
, pp. 1-13
-
-
Levitzki, A.1
-
3
-
-
0032541658
-
Cell signaling: An overview
-
Dhanasekaran, N. (1998) Cell signaling: an overview. Oncogene 17, 1329-1330.
-
(1998)
Oncogene
, vol.17
, pp. 1329-1330
-
-
Dhanasekaran, N.1
-
4
-
-
0034644539
-
Cell signaling by receptor tyrosine kinases
-
Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases. Cell 103, 211-225.
-
(2000)
Cell
, vol.103
, pp. 211-225
-
-
Schlessinger, J.1
-
5
-
-
0034722889
-
The EGF receptor family as targets for cancer therapy
-
Mendelsohn, J. and Baselga, J. (2000) The EGF receptor family as targets for cancer therapy. Oncogene 19, 6550-6565.
-
(2000)
Oncogene
, vol.19
, pp. 6550-6565
-
-
Mendelsohn, J.1
Baselga, J.2
-
6
-
-
0032541650
-
Increasing complexity of Ras signaling
-
Campbell, L., Khosravi-Far, R., Rossmann, K. L., Clark, G. J., and Der, C. J. (1998) Increasing complexity of Ras signaling. Oncogene 17, 1395-1413.
-
(1998)
Oncogene
, vol.17
, pp. 1395-1413
-
-
Campbell, L.1
Khosravi-Far, R.2
Rossmann, K.L.3
Clark, G.J.4
Der, C.J.5
-
7
-
-
0037032835
-
The protein kinase complement of the human genome
-
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science 298, 1912-1934.
-
(2002)
Science
, vol.298
, pp. 1912-1934
-
-
Manning, G.1
Whyte, D.B.2
Martinez, R.3
Hunter, T.4
Sudarsanam, S.5
-
8
-
-
2442701289
-
The ErbB/HER receptor protein-tyrosine kinases and cancer
-
Roskoski, R. (2004) The ErbB/HER receptor protein-tyrosine kinases and cancer. Bioch. Biophys. Res. Commun. 319, 1-11.
-
(2004)
Bioch. Biophys. Res. Commun
, vol.319
, pp. 1-11
-
-
Roskoski, R.1
-
9
-
-
0034658698
-
STATs in oncogenesis
-
Bowman, T., Garcia, R., Turkson, R., and Jove, R. (2000) STATs in oncogenesis. Oncogene 19, 2474-2488.
-
(2000)
Oncogene
, vol.19
, pp. 2474-2488
-
-
Bowman, T.1
Garcia, R.2
Turkson, R.3
Jove, R.4
-
10
-
-
0031893214
-
-
Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W., and Darnell, J. E., Jr. (1998) Mol. Cell. Biol. 18, 2553-2558.
-
(1998)
Mol. Cell. Biol
, vol.18
, pp. 2553-2558
-
-
Bromberg, J.F.1
Horvath, C.M.2
Besser, D.3
Lathem, W.W.4
Darnell Jr., J.E.5
-
11
-
-
0033529704
-
Stat3 as an oncogene
-
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., et al. (1999) Stat3 as an oncogene. Cell 98, 295-303.
-
(1999)
Cell
, vol.98
, pp. 295-303
-
-
Bromberg, J.F.1
Wrzeszczynska, M.H.2
Devgan, G.3
-
12
-
-
0033895709
-
Wnt signalling and cancer
-
Polakis, P. (2000) Wnt signalling and cancer. Genes Devel. 14, 1837-1851.
-
(2000)
Genes Devel
, vol.14
, pp. 1837-1851
-
-
Polakis, P.1
-
13
-
-
0030592517
-
Lessons from hereditary colorectal cancer
-
Kinzler, K. W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell 87, 159-170.
-
(1996)
Cell
, vol.87
, pp. 159-170
-
-
Kinzler, K.W.1
Vogelstein, B.2
-
14
-
-
0028082161
-
Protein kinase C - a question of specificity
-
Dekker, L. V. and Parker, P. J. (1994) Protein kinase C - a question of specificity. TIBS 19, 73-77.
-
(1994)
TIBS
, vol.19
, pp. 73-77
-
-
Dekker, L.V.1
Parker, P.J.2
-
15
-
-
0027322679
-
Protein kinase C isoenzymes: Divergence in signal transduction?
-
Hug, H. and Sarre, T. F. (1993) Protein kinase C isoenzymes: divergence in signal transduction? Biochem. J. 291, 329-343.
-
(1993)
Biochem. J
, vol.291
, pp. 329-343
-
-
Hug, H.1
Sarre, T.F.2
-
16
-
-
0033971901
-
Bcl-2 family: Life-or-death switch
-
Tsujimoto, Y. and Shimizu, S. (2000) Bcl-2 family: life-or-death switch. FEBS Letters 466, 6-10.
-
(2000)
FEBS Letters
, vol.466
, pp. 6-10
-
-
Tsujimoto, Y.1
Shimizu, S.2
-
17
-
-
0030795866
-
Bcl-2 and Bcl-xL can differentially block chemotherapy-induced cell death
-
Simonian, P. L., Grillot, D. A., and Nunez, G. (1997) Bcl-2 and Bcl-xL can differentially block chemotherapy-induced cell death. Blood 90, 1208-1216.
-
(1997)
Blood
, vol.90
, pp. 1208-1216
-
-
Simonian, P.L.1
Grillot, D.A.2
Nunez, G.3
-
18
-
-
0028322065
-
Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma
-
Dole, M., Nunez, G., Merchant, A. K., et al. (1994) Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res. 54, 3253-3259.
-
(1994)
Cancer Res
, vol.54
, pp. 3253-3259
-
-
Dole, M.1
Nunez, G.2
Merchant, A.K.3
-
19
-
-
0035884231
-
The epidermal growth factor receptor: From mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia
-
Arteaga, C. L. (2001) The epidermal growth factor receptor: From mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J. Clin. Oncol. 19, S32-S40.
-
(2001)
J. Clin. Oncol
, vol.19
-
-
Arteaga, C.L.1
-
20
-
-
0034778447
-
EGFR and cancer prognosis
-
Nicholson, R. I., Gee, J. M., and Harper, M. E. (2001) EGFR and cancer prognosis. Eur. J. Cancer 37, 9-15.
-
(2001)
Eur. J. Cancer
, vol.37
, pp. 9-15
-
-
Nicholson, R.I.1
Gee, J.M.2
Harper, M.E.3
-
21
-
-
0035122438
-
The value of the human epidermal growth factor receptor-2 (Her-2) as a prognostic marker
-
Cooke, T., Reeves, J., Lannigan, A., and Stanton, P. (2001) The value of the human epidermal growth factor receptor-2 (Her-2) as a prognostic marker. Eur. J. Cancer. 37, 3-10.
-
(2001)
Eur. J. Cancer
, vol.37
, pp. 3-10
-
-
Cooke, T.1
Reeves, J.2
Lannigan, A.3
Stanton, P.4
-
22
-
-
1242270613
-
The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: A review of preclinical and correlative clinical data
-
Chakravarti, A. Dicker, A., and Mehta, M. (2004) The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data. Int. J. Rad. Oncol. Biol. Phys. 58, 927-931.
-
(2004)
Int. J. Rad. Oncol. Biol. Phys
, vol.58
, pp. 927-931
-
-
Chakravarti, A.1
Dicker, A.2
Mehta, M.3
-
23
-
-
0026548240
-
Structural alterations of the epidermal growth factor receptor gene in human gliomas
-
Wong, A. J., Ruppert, J. M., Bigner, S. H., et al. (1992) Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci. USA 89, 2965-2969.
-
(1992)
Proc. Natl. Acad. Sci. USA
, vol.89
, pp. 2965-2969
-
-
Wong, A.J.1
Ruppert, J.M.2
Bigner, S.H.3
-
24
-
-
0025313141
-
Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma
-
Humphrey, P. A., Wong, A. J., Vogelstein, B., et al. (1990) Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc. Natl. Acad. Sci. USA 87, 4207-4211.
-
(1990)
Proc. Natl. Acad. Sci. USA
, vol.87
, pp. 4207-4211
-
-
Humphrey, P.A.1
Wong, A.J.2
Vogelstein, B.3
-
25
-
-
0032875428
-
Basic science of HER-2/neu: A Review
-
Hung, M. -C. and Lau, Y. -K. (1999) Basic science of HER-2/neu: A Review. Semin. Oncol. 26, 51-59.
-
(1999)
Semin. Oncol
, vol.26
, pp. 51-59
-
-
Hung, M.-C.1
Lau, Y.-K.2
-
26
-
-
0032510109
-
Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes
-
Amundadottir, L. T. and Leder, P. (1998) Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene 16, 737-746.
-
(1998)
Oncogene
, vol.16
, pp. 737-746
-
-
Amundadottir, L.T.1
Leder, P.2
-
27
-
-
18144399578
-
mTOR-targeted therapy of cancer with rapamycin derivatives
-
Vignot, S., Faivre, S., Aguirre, D., and Raymond, E. (2005) mTOR-targeted therapy of cancer with rapamycin derivatives. Ann. Oncol. 16, 525-537.
-
(2005)
Ann. Oncol
, vol.16
, pp. 525-537
-
-
Vignot, S.1
Faivre, S.2
Aguirre, D.3
Raymond, E.4
-
28
-
-
1242338152
-
The HER receptor family: A rich target for therapeutic development
-
Mass, R. D. (2004) The HER receptor family: a rich target for therapeutic development. Int. J. Rad. Oncol. Biol. Phys. 58, 932-940.
-
(2004)
Int. J. Rad. Oncol. Biol. Phys
, vol.58
, pp. 932-940
-
-
Mass, R.D.1
-
29
-
-
21244467171
-
Antibody therapy for breast cancer
-
Willems, A., Gauger, K., Henrichs, C., and Harbeck, N. (2005) Antibody therapy for breast cancer. Anticancer Res. 25, 1483-1489.
-
(2005)
Anticancer Res
, vol.25
, pp. 1483-1489
-
-
Willems, A.1
Gauger, K.2
Henrichs, C.3
Harbeck, N.4
-
30
-
-
0034722887
-
Design of growth factor antagonists with antiangiogenic and antitumor properties
-
Sebti, S. M. and Hamilton, A. D. (2000) Design of growth factor antagonists with antiangiogenic and antitumor properties. Oncogene 19, 6566-6573.
-
(2000)
Oncogene
, vol.19
, pp. 6566-6573
-
-
Sebti, S.M.1
Hamilton, A.D.2
-
31
-
-
0034670036
-
The molecular biology of chronic myeloid leukaemia
-
Deininger, M., Goldman, J., and Melo, J. (2000) The molecular biology of chronic myeloid leukaemia. Blood 96, 3343-3356.
-
(2000)
Blood
, vol.96
, pp. 3343-3356
-
-
Deininger, M.1
Goldman, J.2
Melo, J.3
-
32
-
-
0020972981
-
Translocation of c-abl oncogene correlates with the presence of the Philadelphia chromosome in chronic myelocytic leukemia
-
Bartram, C., de Klein, A., and Hagemeijer, A. (1983) Translocation of c-abl oncogene correlates with the presence of the Philadelphia chromosome in chronic myelocytic leukemia. Nature 306, 277-280.
-
(1983)
Nature
, vol.306
, pp. 277-280
-
-
Bartram, C.1
de Klein, A.2
Hagemeijer, A.3
-
33
-
-
0024376173
-
Ras oncogenes in human cancer
-
Bos, J. L. (1989) Ras oncogenes in human cancer. Cancer Res. 49, 4682-4689.
-
(1989)
Cancer Res
, vol.49
, pp. 4682-4689
-
-
Bos, J.L.1
-
34
-
-
0035908493
-
Blocking oncogenic Ras signaling for cancer therapy
-
Adjei, A. A. (2001) Blocking oncogenic Ras signaling for cancer therapy. J. Natl. Cancer Inst. 93, 1062-1074.
-
(2001)
J. Natl. Cancer Inst
, vol.93
, pp. 1062-1074
-
-
Adjei, A.A.1
-
35
-
-
0035240617
-
Farnesyltransferase inhibitors: A novel targeted therapy for cancer
-
Johnston, S. R. (2001) Farnesyltransferase inhibitors: a novel targeted therapy for cancer. Lancet Oncol. 2, 18-26.
-
(2001)
Lancet Oncol
, vol.2
, pp. 18-26
-
-
Johnston, S.R.1
-
36
-
-
0036031772
-
Therapeutics targeting signal transduction for patients with colorectal carcinoma
-
De Bono, J. S. and Rowinsky, E. K. (2002) Therapeutics targeting signal transduction for patients with colorectal carcinoma. Br. Med. Bulletin. 64, 227-254.
-
(2002)
Br. Med. Bulletin
, vol.64
, pp. 227-254
-
-
De Bono, J.S.1
Rowinsky, E.K.2
-
37
-
-
0030838791
-
In vitro and in vivo activity of antisense inhibitors of ras: Potential for clinical development
-
Cowsert, L. M. (1997) In vitro and in vivo activity of antisense inhibitors of ras: potential for clinical development. Anticancer Drug. Des. 12, 359-371.
-
(1997)
Anticancer Drug. Des
, vol.12
, pp. 359-371
-
-
Cowsert, L.M.1
-
38
-
-
0026774939
-
Selective inhibition of mutant Ha-Ras mRNA expression by antisense oligonucleotides
-
Monia, B. P., Ecker, D. J., Zounes, M. A., Lima, W. F., and Freier, S. M. (1992) Selective inhibition of mutant Ha-Ras mRNA expression by antisense oligonucleotides. J. Biol. Chem. 267, 19,954-19,962.
-
(1992)
J. Biol. Chem
, vol.267
-
-
Monia, B.P.1
Ecker, D.J.2
Zounes, M.A.3
Lima, W.F.4
Freier, S.M.5
-
39
-
-
0029183367
-
Raf-1 protein expression in human breast cancer cells
-
Callans, L. S., Naama, H., Khandelwal, M., Plotkin, R., and Jardines, L. (1995) Raf-1 protein expression in human breast cancer cells. Ann. Surg. Oncol. 2, 38-42.
-
(1995)
Ann. Surg. Oncol
, vol.2
, pp. 38-42
-
-
Callans, L.S.1
Naama, H.2
Khandelwal, M.3
Plotkin, R.4
Jardines, L.5
-
40
-
-
0024583137
-
Loss of heterozygosity of the c-raf locus in small cell lung carcionoma
-
Sithanandam, G., Dean, M., Brennscheidt, U., et al. (1989) Loss of heterozygosity of the c-raf locus in small cell lung carcionoma. Oncogene 4, 451-455.
-
(1989)
Oncogene
, vol.4
, pp. 451-455
-
-
Sithanandam, G.1
Dean, M.2
Brennscheidt, U.3
-
42
-
-
0027996763
-
Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: Reconstitution of the signalling pathway in vitro
-
Marquardt, B., Frith, D., and Stabel, S. (1994) Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene 9, 3213-3218.
-
(1994)
Oncogene
, vol.9
, pp. 3213-3218
-
-
Marquardt, B.1
Frith, D.2
Stabel, S.3
-
43
-
-
0034784725
-
Discovery of a novel Raf kinase inhibitor
-
Lyons, J. F., Wilhelm, S., Hibner, B., and Bollag, G. (2001) Discovery of a novel Raf kinase inhibitor. Endocr. Relat. Cancer 8, 219-225.
-
(2001)
Endocr. Relat. Cancer
, vol.8
, pp. 219-225
-
-
Lyons, J.F.1
Wilhelm, S.2
Hibner, B.3
Bollag, G.4
-
44
-
-
0036624790
-
Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth
-
Iversen, P. O., Emanuel, P. D., and Sioud, M. (2002) Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth. Blood 99, 4147-4153.
-
(2002)
Blood
, vol.99
, pp. 4147-4153
-
-
Iversen, P.O.1
Emanuel, P.D.2
Sioud, M.3
-
45
-
-
0029977448
-
Antitumor activity of phosphorothioate antisense oligodeoxynucleotide targeted against c-Raf kinase
-
Monia, B. P., Johnston, J. F., Geiger, T., Muller, M., and Fabbro, D. (1996) Antitumor activity of phosphorothioate antisense oligodeoxynucleotide targeted against c-Raf kinase. Nat. Med. 2, 668-675.
-
(1996)
Nat. Med
, vol.2
, pp. 668-675
-
-
Monia, B.P.1
Johnston, J.F.2
Geiger, T.3
Muller, M.4
Fabbro, D.5
-
46
-
-
0034722894
-
Development of anticancer drugs targeting the MAP kinase pathway
-
Sebolt-Leopold, J. S. (2000) Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 19, 6594-6599.
-
(2000)
Oncogene
, vol.19
, pp. 6594-6599
-
-
Sebolt-Leopold, J.S.1
-
47
-
-
0029166667
-
A synthetic inhibitor of the mitogen-activated protein kinase cascade
-
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., and Saltiel, A. R. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92, 7686-7689.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 7686-7689
-
-
Dudley, D.T.1
Pang, L.2
Decker, S.J.3
Bridges, A.J.4
Saltiel, A.R.5
-
48
-
-
0032984348
-
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
-
Sebolt-Leopold, J. S., Dudley, D. T., Herrera, R., et al. (1999) Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5, 810-816.
-
(1999)
Nat. Med
, vol.5
, pp. 810-816
-
-
Sebolt-Leopold, J.S.1
Dudley, D.T.2
Herrera, R.3
-
49
-
-
0032935664
-
Mitogen-activated protein kinases: Specific messages from ubiquitous messengers
-
Schaeffer, H. J. and Weber, M. J. (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19, 2435-2444.
-
(1999)
Mol. Cell. Biol
, vol.19
, pp. 2435-2444
-
-
Schaeffer, H.J.1
Weber, M.J.2
-
50
-
-
0025823448
-
ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin
-
Boulton, G., Nye, S. H., Robbibs, D. J., et al. (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin. Cell 65, 663-675.
-
(1991)
Cell
, vol.65
, pp. 663-675
-
-
Boulton, G.1
Nye, S.H.2
Robbibs, D.J.3
-
51
-
-
0033545565
-
Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells
-
Plattner, R., Gupta, S., Khosravi-Far, R., et al. (1999) Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells. Oncogene 18, 1807-1817.
-
(1999)
Oncogene
, vol.18
, pp. 1807-1817
-
-
Plattner, R.1
Gupta, S.2
Khosravi-Far, R.3
-
52
-
-
0034648695
-
Interference with the constitutive activation of ERKl and ERK2 impairs EWS/FLI-1-dependent transformation
-
Silvany, R. E., Eliazer, S., Wolff, N. C., and Ilaria, R. L., Jr. (2000) Interference with the constitutive activation of ERKl and ERK2 impairs EWS/FLI-1-dependent transformation. Oncogene 19, 4523-4530.
-
(2000)
Oncogene
, vol.19
, pp. 4523-4530
-
-
Silvany, R.E.1
Eliazer, S.2
Wolff, N.C.3
Ilaria Jr., R.L.4
-
53
-
-
0027742729
-
Interferoninduced nuclear signaling by Jak protein tyrosine kinases
-
Silvennoinen, O., Ihle, J. N., Schlessinger, J., and Levy, D. E. (1993) Interferoninduced nuclear signaling by Jak protein tyrosine kinases. Nature 366, 583-585.
-
(1993)
Nature
, vol.366
, pp. 583-585
-
-
Silvennoinen, O.1
Ihle, J.N.2
Schlessinger, J.3
Levy, D.E.4
-
54
-
-
0036233585
-
Cytokine signaling in 2002: New surprises in the JAK/STAT pathway
-
O'Shea, J. J., Gadina, M., and Schreiber, R. D. (2002) Cytokine signaling in 2002: new surprises in the JAK/STAT pathway. Cell 109, S121-S131.
-
(2002)
Cell
, vol.109
-
-
O'Shea, J.J.1
Gadina, M.2
Schreiber, R.D.3
-
55
-
-
0036256836
-
JAK-STAT signaling in human disease
-
Schindler, C. W. (2002) JAK-STAT signaling in human disease. J. Clin. Invest. 109, 1133-1137.
-
(2002)
J. Clin. Invest
, vol.109
, pp. 1133-1137
-
-
Schindler, C.W.1
-
56
-
-
0037304457
-
A reinterpretation of the dimerization interface of the N-terminal domains of STATs
-
Chen, X., Bhandari, R., Vinkermeier, U., Van Den Akker, F., Darnell, J. E., Jr., and Kuriyan, J. (2003) A reinterpretation of the dimerization interface of the N-terminal domains of STATs. Protein Sci. 12, 361-365.
-
(2003)
Protein Sci
, vol.12
, pp. 361-365
-
-
Chen, X.1
Bhandari, R.2
Vinkermeier, U.3
Van Den Akker, F.4
Darnell Jr., J.E.5
Kuriyan, J.6
-
57
-
-
1542327277
-
Inhibitors of JAKs/STATs and the kinases: A possible new cluster of drugs
-
Luo, C. and Laaja, P. (2004) Inhibitors of JAKs/STATs and the kinases: a possible new cluster of drugs. DDT 9, 268-275.
-
(2004)
DDT
, vol.9
, pp. 268-275
-
-
Luo, C.1
Laaja, P.2
-
58
-
-
0031893214
-
Stat 3 activation is required for cellular transformation by v-src
-
Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W., and Darnell, J. E., Jr. (1998) Stat 3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18, 2553-2558.
-
(1998)
Mol. Cell. Biol
, vol.18
, pp. 2553-2558
-
-
Bromberg, J.F.1
Horvath, C.M.2
Besser, D.3
Lathem, W.W.4
Darnell Jr., J.E.5
-
59
-
-
0034722896
-
STAT proteins: Novel molecular targets for cancer drug discovery
-
Turkson, J. and Jove, R. (2000) STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19, 6613-6626.
-
(2000)
Oncogene
, vol.19
, pp. 6613-6626
-
-
Turkson, J.1
Jove, R.2
-
60
-
-
0242285719
-
STAT proteins: From normal control of cellular events to tumorigenesis
-
Calo, V., Migliavacca, M., Bazan, V., et al. (2003) STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell. Physiol. 197, 157-168.
-
(2003)
J. Cell. Physiol
, vol.197
, pp. 157-168
-
-
Calo, V.1
Migliavacca, M.2
Bazan, V.3
-
61
-
-
0035977055
-
Phosphotyrosyl peptides block Stat3-mediated DNA-binding activity, gene regulation, and cell transformation
-
Turkson, J., Ryan, D., Kim, J. S., et al. (2001) Phosphotyrosyl peptides block Stat3-mediated DNA-binding activity, gene regulation, and cell transformation. /. Biol. Chem. 276, 45,443-45,455.
-
(2001)
Biol. Chem
, vol.276
-
-
Turkson, J.1
Ryan, D.2
Kim, J.S.3
-
62
-
-
0026451081
-
Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
-
Nishizuka, Y. (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258, 607-614.
-
(1992)
Science
, vol.258
, pp. 607-614
-
-
Nishizuka, Y.1
-
63
-
-
0020634260
-
Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters
-
Kikkawa, U., Takai, Y., Tanaka, Y., Miyake, R., and Nishizuka, Y. (1983) Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. J. Biol. Chem. 258, 11,442-11,445.
-
(1983)
J. Biol. Chem
, vol.258
-
-
Kikkawa, U.1
Takai, Y.2
Tanaka, Y.3
Miyake, R.4
Nishizuka, Y.5
-
64
-
-
0023880172
-
Protein kinase C as the receptor for the phorbol ester tumor promoters: Sixth roads memorial award lecture
-
Blumberg, P. M. (1988) Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth roads memorial award lecture. Cancer Res. 48, 1-8.
-
(1988)
Cancer Res
, vol.48
, pp. 1-8
-
-
Blumberg, P.M.1
-
65
-
-
0036177115
-
Targeting protein kinase C: New terapeutic opportunities against high-grade malignant gliomas
-
Rocha, A. B., Mans, D. R. A., Regner, A., and Schwartsmann, G. (2002) Targeting protein kinase C: new terapeutic opportunities against high-grade malignant gliomas. The Oncologist 7, 17-33.
-
(2002)
The Oncologist
, vol.7
, pp. 17-33
-
-
Rocha, A.B.1
Mans, D.R.A.2
Regner, A.3
Schwartsmann, G.4
-
66
-
-
0031864708
-
A nuclease-resistant protein kinase C alpha ribozyme blocks glioma cell growth
-
Sioud, M. and Sørensen, D. R. (1998) A nuclease-resistant protein kinase C alpha ribozyme blocks glioma cell growth. Nat. Biotechnol. 16, 556-561.
-
(1998)
Nat. Biotechnol
, vol.16
, pp. 556-561
-
-
Sioud, M.1
Sørensen, D.R.2
-
67
-
-
0032990503
-
Ribozyme inhinition of the protein kinase Ca triggers apoptosis in glioma cells
-
Leirdal, M. and Sioud, M. (1999) Ribozyme inhinition of the protein kinase Ca triggers apoptosis in glioma cells. Br. J. Cancer. 80, 1558-1564.
-
(1999)
Br. J. Cancer
, vol.80
, pp. 1558-1564
-
-
Leirdal, M.1
Sioud, M.2
-
68
-
-
0034711950
-
Design of nuclease resistant protein kinase Ca DNA enzymes with potential therapeutic application
-
Sioud, M. and Leirdal, M. (2000) Design of nuclease resistant protein kinase Ca DNA enzymes with potential therapeutic application. J. Mol. Biol. 296, 937-947.
-
(2000)
J. Mol. Biol
, vol.296
, pp. 937-947
-
-
Sioud, M.1
Leirdal, M.2
-
69
-
-
0031963427
-
Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice
-
Geiger, T., Muller, M., Dean, N. M., and Fabbro, D. (1998) Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice. Anticancer Drug Des. 13, 35-45.
-
(1998)
Anticancer Drug Des
, vol.13
, pp. 35-45
-
-
Geiger, T.1
Muller, M.2
Dean, N.M.3
Fabbro, D.4
-
70
-
-
0032409781
-
Bcl-2 family proteins
-
Reed, J. C. (1998) Bcl-2 family proteins. Oncogene 17, 3225-3236.
-
(1998)
Oncogene
, vol.17
, pp. 3225-3236
-
-
Reed, J.C.1
-
71
-
-
0032580361
-
Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins
-
Zamzami, N., Brenner, C., Marzo, I., Susin, S. A., and Kroemer, G. (1998) Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene 16, 2265-2282.
-
(1998)
Oncogene
, vol.16
, pp. 2265-2282
-
-
Zamzami, N.1
Brenner, C.2
Marzo, I.3
Susin, S.A.4
Kroemer, G.5
-
72
-
-
5244224827
-
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death
-
Muchmore, S. W., Sattler, M., Liang, H., et al. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death Nature 381, 335-341.
-
(1996)
Nature
, vol.381
, pp. 335-341
-
-
Muchmore, S.W.1
Sattler, M.2
Liang, H.3
-
73
-
-
20444486559
-
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
-
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., et al. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435, 677-681.
-
(2005)
Nature
, vol.435
, pp. 677-681
-
-
Oltersdorf, T.1
Elmore, S.W.2
Shoemaker, A.R.3
-
74
-
-
0030807543
-
A novel antisense oligonucleotide targeting the coding region of the bcl-2 mRNA is a potent inducer of apoptosis in small cell lung cancer cells
-
Ziegler, A., Luedke, G. H., Fabbro, D., Altmann, K. H., Stahel, R. A., and Zangemeister-Wittke, U. (1997) A novel antisense oligonucleotide targeting the coding region of the bcl-2 mRNA is a potent inducer of apoptosis in small cell lung cancer cells. J. Natl. Cancer Inst. 89, 1027-1036.
-
(1997)
J. Natl. Cancer Inst
, vol.89
, pp. 1027-1036
-
-
Ziegler, A.1
Luedke, G.H.2
Fabbro, D.3
Altmann, K.H.4
Stahel, R.A.5
Zangemeister-Wittke, U.6
-
75
-
-
0034071150
-
Induction of apoptosis in lung cancer cells following bcl-xL antisense treatment
-
Leech, S. H., Olie, R. A., Gautschi, O., et al. (2000) Induction of apoptosis in lung cancer cells following bcl-xL antisense treatment. Int. J. Cancer. 86, 570-576.
-
(2000)
Int. J. Cancer
, vol.86
, pp. 570-576
-
-
Leech, S.H.1
Olie, R.A.2
Gautschi, O.3
-
76
-
-
0036830417
-
Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphoamide
-
Simoes-Wust, A., Schurpf, T., Hall, J., Stahel, R. A., and Zangmeister-wittke, U. (2002) Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphoamide. Breast. Cancer. Res. Treat. 76, 157-166.
-
(2002)
Breast. Cancer. Res. Treat
, vol.76
, pp. 157-166
-
-
Simoes-Wust, A.1
Schurpf, T.2
Hall, J.3
Stahel, R.A.4
Zangmeister-wittke, U.5
-
77
-
-
0035902141
-
The microenvironment of the tumour-host interface
-
Liotta, L. A. and Kohn, E. C. (2001) The microenvironment of the tumour-host interface. Nature 411, 375-379.
-
(2001)
Nature
, vol.411
, pp. 375-379
-
-
Liotta, L.A.1
Kohn, E.C.2
-
78
-
-
3442901908
-
Colony-stimulating factor-1 blockage by antisense oligonucleotides and small-interfering RNAs suppresses growth of human mammary tumor xenografts in mice
-
Aharinejad, S., Paulus, P., Sioud, M., et al. (2004) Colony-stimulating factor-1 blockage by antisense oligonucleotides and small-interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Caner Res. 64, 5378-5384.
-
(2004)
Caner Res
, vol.64
, pp. 5378-5384
-
-
Aharinejad, S.1
Paulus, P.2
Sioud, M.3
|